Neurocrine Biosciences (NBIX) Reports Prelim. Q4 Net Sales Above Consensus, Prelim. FY19 Net Sales Below Consensus; Provides 2020 Program Milestones - StreetInsider.com

Submitted by Anonymous (not verified) on Mon, 01/13/2020 - 11:00

Neurocrine Biosciences (NBIX) Reports Prelim. Q4 Net Sales Above Consensus, Prelim. FY19 Net Sales Below Consensus; Provides 2020 Program Milestones  StreetInsider.com